Illumina Inc
NASDAQ: ILMN
$142.24
-$3.93 (-2.7%)
Closing Price on November 14, 2024
ILMN Articles
Tuesday's top analyst upgrades and downgrades include AcelRx Pharmaceuticals, AECOM, Electronic Arts, Hewlett-Packard, Myriad Genetics and Urban Outfitters.
Published:
24/7 Wall St. reviewed the new Credit Suisse Top Picks for 2015 report, and here are five of the top health care picks.
Published:
A new research report from the analysts at Cowen highlights the firm's top health care picks, many of which have some huge upside potential to the posted price targets.
Published:
With the bull market nearing six years old, 24/7 Wall St. has identified 11 large and well-known stocks that are valued at over 50 times earnings.
Published:
A new report from Cowen makes the case that a blood test that detects evidence of cancer in the circulation could soon replace the older more traditional biopsy methods.
Published:
ThinkstockIllumina Inc. (NASDAQ: ILMN) reported its earnings before the market opened Monday as $0.77 in earnings per share and $481 in revenue which beat out consensus estimates. On the heels of...
Published:
These are the top analyst upgrades and downgrades featured by 24/7 Wall St. for Thursday, October 16, 2014.
Published:
Jon OggStocks were holding on to small gains on Tuesday even after weaker sentiment was reported out of Europe. It looks as though investors have decided they can now shop around for stocks that have...
Published:
ThinkstockEarnings season is now well under way for the second quarter. So far, things are looking good. The biotech sector has yet to see any significant earnings representation. That will change...
Published:
These are the top analyst upgrades, downgrades and initiations from Wall Street firms on Thursday, July 17, 2014. They include AIG, Intel, eBay, EOG Resources, PetSmart and Time Warner.
Published:
courtesy of WynnResorts.comThe stock market looks wobbly and that may be starting to make many investors nervous. While in the short-term we may be looking at a correction, the long-term prospects...
Published:
These are the top Wall Street analyst upgrades, downgrades and initiations seen on Wednesday, April 23, 2014. They include Allergan, Galmed Pharmaceuticals, GM, Sirius XM and SunPower.
Published:
In a new research report from Deutsche Bank that looks at how the market sets up for the rest of the year, the firm has a list of the 25 largest U.S. market cap companies not in the S&P 500 Index.
Published:
In a new research report, the J.P. Morgan health care team highlights their top names to buy after the sell-off that may provide investors some incredible outsized gains over the rest of the year.
Published:
thinkstockApril 16, 2014: Markets opened higher on Wednesday with shares getting a boost in midmorning from the report on crude oil and gasoline stockpiles. The midafternoon release of the Fed’s...
Published:
Last Updated: